Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials
- Laurent Peyrin-Biroulet
- , Subrata Ghosh
- , Scott D. Lee
- , Wan Ju Lee
- , Jenny Griffith
- , Kori Wallace
- , Sofie Berg
- , Xiaomei Liao
- , Julian Panes
- , Edward V. Loftus
- , Edouard Louis
- Université de Lorraine
- University of Washington
- AbbVie
- August Pi i Sunyer Biomedical Research Institute
- Mayo Clinic Rochester, MN
- University of Liege
Research output: Contribution to journal › Article › peer-review